CLSI C52-A2

Toxicology and Drug Testing in the Clinical Laboratory; Approved Guideline, Second Edition, C52A2E

Clinical and Laboratory Standards Institute, 04/01/2007

Publisher: CLSI

File Format: PDF

$143.00$287.20

Description

Published:01/04/2007

Pages:68

This guideline addresses drug testing in the clinical laboratory, both for clinical and forensic purposes, and pertains to both drugs of abuse and other drugs normally encountered and analyzed by hospital laboratories.

The guideline discusses the preanalytical, analytical, and postanalytical considerations for specimen collection, methods of analysis, quality assurance, and the reporting and interpretation of results.

More CLSI standard pdf

CLSI M51-P

Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Proposed Guideline, M51P

$102.00 $205.93

CLSI M44-A2

Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline--Second Edition, M44A2

$100.00 $200.00

CLSI I/LA33-P

Validation of Automated Devices for Immunohematologic Testing Prior to Implementation; Proposed Guideline, ILA33PE

$108.00 $217.13

CLSI EP18-P3

Risk Management Techniques to Identify and Control Laboratory Error Sources; Proposed Guideline, Third Edition; EP18P3

$144.00 $289.95